{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:04:28Z","timestamp":1791936268252,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2004,9,8]],"date-time":"2004-09-08T00:00:00Z","timestamp":1094601600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1038\/sj.npp.1300558","type":"journal-article","created":{"date-parts":[[2004,9,8]],"date-time":"2004-09-08T04:19:22Z","timestamp":1094617162000},"page":"2108-2114","source":"Crossref","is-referenced-by-count":406,"title":["Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms"],"prefix":"10.1038","volume":"29","author":[{"given":"Andrea","family":"Giuffrida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F Markus","family":"Leweke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph W","family":"Gerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Koethe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Faulhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Klosterk\u00f6tter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Piomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,9,8]]},"reference":[{"key":"BF1300558_CR1","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","volume":"97","author":"A Abi-Dargham","year":"2000","unstructured":"Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS et al (2000). Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA 97: 8104\u20138109.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1300558_CR2","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","volume":"2","author":"S Andr\u00e9asson","year":"1987","unstructured":"Andr\u00e9asson S, Allebeck P, Engstr\u00f6m A, Rydberg U (1987). Cannabis and schizophrenia. Lancet 2: 1483\u20131486.","journal-title":"Lancet"},{"key":"BF1300558_CR3","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","volume":"325","author":"L Arseneault","year":"2002","unstructured":"Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325: 1212\u20131213.","journal-title":"BMJ"},{"key":"BF1300558_CR4","first-page":"S188","volume":"5","author":"L Arvanitis","year":"2002","unstructured":"Arvanitis L, Bauer D, Rein W (2002). Results of the metatrial project: efficacy and tolerability of four novel compounds in schizophrenia and schizoaffective disorder. Int J Neuropsychopharmacol 5: S188.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BF1300558_CR5","unstructured":"American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th DMS-IV edn. American Psychiatric Press Inc.: Washington, DC."},{"key":"BF1300558_CR6","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1523\/JNEUROSCI.20-09-03401.2000","volume":"20","author":"M Beltramo","year":"2000","unstructured":"Beltramo M, Rodriguez de Fonseca F, Navarro M, Calignano A, Gorriti MA, Grammatikopoulos G et al (2000). Reversal of dopamine D2-receptor responses by an anandamide transport inhibitor. J Neurosci 20: 3401\u20133407.","journal-title":"J Neurosci"},{"key":"BF1300558_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/28393","volume":"394","author":"A Calignano","year":"1998","unstructured":"Calignano A, La Rana G, Giuffrida A, Piomelli D (1998). Control of pain initiation by endogenous cannabinoids. Nature 394: 277\u2013281.","journal-title":"Nature"},{"key":"BF1300558_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","volume":"103","author":"B Dean","year":"2001","unstructured":"Dean B, Sundram S, Bradbury R, Scarr E, Copolov D (2001). Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience 103: 9\u201315.","journal-title":"Neuroscience"},{"key":"BF1300558_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1476-511X-2-5","volume":"2","author":"N De Marchi","year":"2003","unstructured":"De Marchi N, De Petrocellis L, Orlando P, Daniele F, Fezza F, Di Marzo V (2003). Endocannabinoid signaling in the blood of patients with schizophrenia. Lipids Health Dis 2: 5.","journal-title":"Lipids Health Dis"},{"key":"BF1300558_CR10","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"W Devane","year":"1992","unstructured":"Devane W, Hanus L, Breuer A, Pertwee R, Stevenson L, Griffin G et al (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946\u20131949.","journal-title":"Science"},{"key":"BF1300558_CR11","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/372686a0","volume":"372","author":"V Di Marzo","year":"1994","unstructured":"Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz J-C et al (1994). Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372: 686\u2013691.","journal-title":"Nature"},{"key":"BF1300558_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0091-3057(96)00426-1","volume":"56","author":"HM Emrich","year":"1997","unstructured":"Emrich HM, Leweke FM, Schneider U (1997). Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacol Biochem Behav 56: 803\u2013807.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300558_CR13","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1046\/j.1460-9568.2003.02896.x","volume":"18","author":"B Ferrer","year":"2003","unstructured":"Ferrer B, Asbrock N, Kathuria S, Piomelli D, Giuffrida A (2003). Effects of levodopa onendocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. Eur J Neurosci 18: 1607\u20131614.","journal-title":"Eur J Neurosci"},{"key":"BF1300558_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature01921","volume":"425","author":"J Fu","year":"2003","unstructured":"Fu J, Gaetani S, Oveisi F, Loverme J, Serrano A, Rodriguez de Fonseca F et al (2003). Oleylethanolamide regulates feeding and body weight through activation of PPAR-\u03b1. Nature 425: 90\u201393.","journal-title":"Nature"},{"key":"BF1300558_CR15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/7268","volume":"2","author":"A Giuffrida","year":"1999","unstructured":"Giuffrida A, Parsons LH, Kerr TM, Rodr\u00edguez de Fonseca F, Navarro M, Piomelli D (1999). Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 2: 358\u2013363.","journal-title":"Nat Neurosci"},{"key":"BF1300558_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1006\/abio.2000.4509","volume":"280","author":"A Giuffrida","year":"2000","unstructured":"Giuffrida A, Rodr\u00edguez de Fonseca F, Piomelli D (2000). Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry. Anal Biochem 280: 87\u201393.","journal-title":"Anal Biochem"},{"key":"BF1300558_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","volume":"77","author":"M Glass","year":"1997","unstructured":"Glass M, Dragunow M, Faull RLM (1997). Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77: 299\u2013318.","journal-title":"Neuroscience"},{"key":"BF1300558_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0014-2999(98)00851-6","volume":"365","author":"MA Gorriti","year":"1999","unstructured":"Gorriti MA, Rodr\u00edguez de Fonseca F, Navarro M, Palomo T (1999). Chronic (\u2212)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats. Eur J Pharmacol 365: 133\u2013142.","journal-title":"Eur J Pharmacol"},{"key":"BF1300558_CR19","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","volume":"87","author":"M Herkenham","year":"1990","unstructured":"Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR et al (1990). Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87: 1932\u20131936.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1300558_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0920-9964(97)00151-5","volume":"30","author":"DF Horrobin","year":"1998","unstructured":"Horrobin DF (1998). The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 30: 193\u2013208.","journal-title":"Schizophr Res"},{"key":"BF1300558_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS). Schizophr Bull 13: 261\u2013276.","journal-title":"Schizophr Bull"},{"key":"BF1300558_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/schbul\/23.2.195","volume":"23","author":"B Kovasznay","year":"1997","unstructured":"Kovasznay B, Fleischer J, Tanenberg-Karant M, Jandorf L, Miller AD, Bromet E (1997). Substance use disorder and the early course of illness in schizophrenia and affective psychosis. Schizophr Bull 23: 195\u2013201.","journal-title":"Schizophr Bull"},{"key":"BF1300558_CR23","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1097\/00001756-199906030-00008","volume":"10","author":"FM Leweke","year":"1999","unstructured":"Leweke FM, Giuffrida A, Wurster U, Emrich HM, Piomelli D (1999b). Elevated endogenous cannabinoids in schizophrenia. NeuroReport 10: 1665\u20131669.","journal-title":"NeuroReport"},{"key":"BF1300558_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s002130050884","volume":"142","author":"FM Leweke","year":"1999","unstructured":"Leweke FM, Schneider U, Thies M, M\u00fcnte TF, Emrich HM (1999a). Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man. Psychopharmacology 142: 230\u2013235.","journal-title":"Psychopharmacology"},{"key":"BF1300558_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1001\/archpsyc.1994.03950040017002","volume":"51","author":"DH Linszen","year":"1994","unstructured":"Linszen DH, Dingemans PM, Lenior ME (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 51: 273\u2013279.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300558_CR26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/cne.903270406","volume":"327","author":"LA Matsuda","year":"1993","unstructured":"Matsuda LA, Bonner TI, Lolait SJ (1993). Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327: 535\u2013550.","journal-title":"J Comp Neurol"},{"key":"BF1300558_CR27","doi-asserted-by":"publisher","first-page":"106S","DOI":"10.1016\/S0893-133X(99)00046-9","volume":"21","author":"HY Meltzer","year":"1999","unstructured":"Meltzer HY (1999). The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21: 106S\u2013115S.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300558_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nn804","volume":"5","author":"A Meyer-Lindenberg","year":"2002","unstructured":"Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M et al (2002). Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 5: 267\u2013271.","journal-title":"Nat Neurosci"},{"key":"BF1300558_CR29","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrn1247","volume":"4","author":"D Piomelli","year":"2003","unstructured":"Piomelli D (2003). The molecular logic of endocannabinoid signaling. Nat Rev Neurosci 4: 873\u2013882.","journal-title":"Nat Rev Neurosci"},{"key":"BF1300558_CR30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/35102582","volume":"414","author":"F Rodr\u00edguez de Fonseca","year":"2001","unstructured":"Rodr\u00edguez de Fonseca F, Navarro M, G\u00f3mez R, Escuredo L, Nava F, Fu J et al (2001). An anorexic lipid mediator regulated by feeding. Nature 414: 209\u2013212.","journal-title":"Nature"},{"key":"BF1300558_CR31","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0091-3057(03)00140-0","volume":"75","author":"DM Semple","year":"2003","unstructured":"Semple DM, Ramsden F, McIntosh AM (2003). Reduced binocular depth inversion in regular cannabis users. Pharmacol Biochem Behav 75: 789\u2013793.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300558_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1124\/jpet.102.035618","volume":"303","author":"LJ Sim-Selley","year":"2002","unstructured":"Sim-Selley LJ, Martin BR (2002). Effect of chronic administration of R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphtalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice. J Pharmacol Exp Ther 303: 36\u201344.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300558_CR33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/sj.mp.4001029","volume":"7","author":"H Ujike","year":"2002","unstructured":"Ujike H, Takaki M, Nakata K, Tanaka Y, Takeda T, Kodama M et al (2002). CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia. Mol Psychiatry 7: 515\u2013518.","journal-title":"Mol Psychiatry"},{"key":"BF1300558_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0925-4927(01)00104-4","volume":"107","author":"LNP Voruganti","year":"2001","unstructured":"Voruganti LNP, Slomka P, Zabel P, Mattar A, Awad AG (2001). Cannabis induced dopamine release: an in-vivo SPECT study. Psychiatry Res: Neuroimaging Sect 107: 173\u2013177.","journal-title":"Psychiatry Res: Neuroimaging Sect"},{"key":"BF1300558_CR35","first-page":"64S","volume":"51","author":"JK Yao","year":"2002","unstructured":"Yao JK, van Kammen DP, Reddy RD, Keshavan MS, Schmid PC, Berdyshev EV et al (2002). Elevated endocannabinoids in plasma from patients with schizophrenia. Biol Psychiatry 51: 64S\u201365S.","journal-title":"Biol Psychiatry"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300558.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300558","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300558.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T02:47:18Z","timestamp":1684205238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,8]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["BF1300558"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300558","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,8]]}}}